Antony Mattessich

Director/Board Member chez AURA BIOSCIENCES, INC. Fortune : 5 M $ au 31/03/2024

Profil

Antony Mattessich is an Independent Non-Executive Director at Aura Biosciences, Inc. He previously served as President, Chief Executive Officer & Director at Mundipharma International Ltd.
from 2009 to 2017.
From 2017 to 2024, he held the same positions at Ocular Therapeutix, Inc. Prior to that, he was the Managing Director & Director at Napp Pharmaceutical Holdings Ltd.
from 2005 to 2011.
Antony also worked at Bristol Myers Squibb Co. as the Head of Operations-International Medicines.
Before that, he was the Head-Therapeutic Franchise at Novartis AG from 2003 to 2005.
Antony completed his graduate degree at The Trustees of Columbia University in The City of New York and his undergraduate degree at the University of California, Berkeley.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OCULAR THERAPEUTIX INC 0,40%	05/02/2024	595 201 ( 0,40% )	5 M $	31/03/2024
AURA BIOSCIENCES INC -.--%	07/06/2023	0 ( -.--% )	- $	31/03/2024

Postes actifs de Antony Mattessich

Sociétés	Poste	Début
AURA BIOSCIENCES, INC.	Director/Board Member	29/09/2021

Anciens postes connus de Antony Mattessich

Sociétés	Poste	Fin
OCULAR THERAPEUTIX, INC.	Chief Executive Officer	15/04/2024
Mundipharma International Ltd.	Chief Executive Officer	18/12/2017
Napp Pharmaceutical Holdings Ltd.	Chief Executive Officer	01/05/2011
NOVARTIS AG	Corporate Officer/Principal	01/01/2005
BRISTOL-MYERS SQUIBB COMPANY	Director/Board Member	-

Formation de Antony Mattessich

The Trustees of Columbia University in The City of New York	Graduate Degree
University of California, Berkeley	Undergraduate Degree